Pre-Prepared Radiopharmaceutical Kits

Description

The Contracting Authorities currently source their pre-prepared radiopharmaceutical kits from external providers holding ‘Special’ licenses, who supply and deliver compounded radiopharmaceutical kits within a specified time and date to enable delivery of patient care and support operational effectiveness. The requirement covers the provision of the following radiopharmaceuticals: Tc99m (Technetium), MAA, HDP/HMDP, MAG3, DMSA, SESTAMIBI, NANOCOLLOID and PERTECHNETATE. These are provided in the form of multi injection vials. This notice is for an award without competition, as a result of too few expressions of interest, subsequent to the PIN, to run a competitive process. It is the expectation of the Contracting Authorities that this will be awarded for a 2 year period. Lot 1: Supply of Pre-Prepared Radiopharmaceutical Kits Great Western Hospitals NHS Foundation Trust The Contracting Authorities currently source their pre-prepared radiopharmaceutical kits from external providers holding ‘Special’ licenses, who supply and deliver compounded radiopharmaceutical kits within a specified time and date to enable delivery of patient care and support operational effectiveness. The requirement covers the provision of the following radiopharmaceuticals: Tc99m (Technetium), MAA, HDP/HMDP, MAG3, DMSA, SESTAMIBI, NANOCOLLOID and PERTECHNETATE. These are provided in the form of multi injection vials. This notice is for an award without competition, as a result of too few expressions of interest, subsequent to the PIN, to run a competitive process. It is the expectation of the Contracting Authorities that this will be awarded for a 2 year period. . Lot 2: Supply of Pre-Prepared Radiopharmaceutical Kits at Salisbury NHS Foundation Trust The Contracting Authorities currently source their pre-prepared radiopharmaceutical kits from external providers holding ‘Special’ licenses, who supply and deliver compounded radiopharmaceutical kits within a specified time and date to enable delivery of patient care and support operational effectiveness. The requirement covers the provision of the following radiopharmaceuticals: Tc99m (Technetium), MAA, HDP/HMDP, MAG3, DMSA, SESTAMIBI, NANOCOLLOID and PERTECHNETATE. These are provided in the form of multi injection vials. This notice is for an award without competition, as a result of too few expressions of interest, subsequent to the PIN, to run a competitive process. It is the expectation of the Contracting Authorities that this will be awarded for a 2 year period. .